Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines-Reference-Cited by-同舟云学术

Cytotoxicity evaluation of curcumin-loaded affibody-decorated liposomes against breast cancerous cell lines

Published:2020-07-03 Issue:2 Volume:31 Page:189-194
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Moballegh-Nasery Mahshid¹²^ORCID,Mandegary Ali²³^ORCID,Eslaminejad Touba²^ORCID,Zeinali Majid⁴^ORCID,Pardakhti Abbas²^ORCID,Behnam Behzad²⁵^ORCID,Mohammadi Mohadeseh⁶^ORCID

Affiliation:

1. Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

2. Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

3. Department of Toxicology & Pharmacology, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran

4. Biotechnology Research Center, Research Institute of Petroleum Industry (RIPI), Tehran, Iran

5. Department of Pharmaceutical Biotechnology, School of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran

6. Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

Funder

the Kerman University of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2020.1755981

Reference31 articles.

1. Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine

2. Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors

3. Comparison of pharmaceutical nanoformulations for curcumin: Enhancement of aqueous solubility and carrier retention

4. 188Re-ZHER2:V2, a Promising Affibody-Based Targeting Agent Against HER2-Expressing Tumors: Preclinical Assessment

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of affibody molecules in biomedical applications;Bioorganic & Medicinal Chemistry;2024-11

2. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges;Drug Delivery and Translational Research;2024-07-13

3. Albumin incorporation into recognising layer of HER2-specific magnetic nanoparticles as a tool for optimal targeting of the acidic tumor microenvironment;Heliyon;2024-07

4. Evaluation of the theranostic characteristics of chitosan-decorated bismuth oxide nanoparticles conjugated curcumin and 5-aminolevulinic acid as a biocompatible targeted nanoplatform in CT and breast cancer radiation therapy;Journal of Drug Delivery Science and Technology;2024-02

5. Enhancing the therapeutic potential of curcumin: a novel nanoformulation for targeted anticancer therapy to colorectal cancer with reduced miR20a and miR21 expression;Biomedical Materials;2024-01-25